Misplaced Trust? Occupational Therapy and NHS Trusts

1994 ◽  
Vol 57 (2) ◽  
pp. 40-44 ◽  
Author(s):  
Walter Lloyd-Smith
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Occupational Therapy ◽  
National Health ◽  
Health Professionals ◽  
The Self ◽  
The Government ◽  
The Impact ◽  
Therapy Service

The present governmental reforms of the National Health Service are the most far-reaching to date and have fundamental implications for health professionals. The focus of this article is to raise some of these issues in relation to occupational therapy. The introduction of trusts, the purchaser/provider split and the internal market are some of the mechanisms by which the government hoped to tackle the funding crisis of the late 1980s. These reforms have been operating since 1991, but little has been published on the impact of the self-governing trust movement on occupational therapy. Some observations on and an evaluation of these reforms are offered. It is hoped that the article will stimulate discussion within the profession about the role of trusts and their relationship to the delivery and development of an occupational therapy service.

Who Owns Quality in the Occupational Therapy Profession and How Do We Assure It?

1992 ◽  
Vol 55 (1) ◽  
pp. 4-6 ◽  
Author(s):  
Anne E K Roberts
Keyword(s):  
Quality Assurance ◽  
National Health Service ◽  
Health Service ◽  
Occupational Therapy ◽  
National Health ◽  
Basic Concepts

This article examines the basic concepts of quality assurance. It explores the ownership of quality assurance within the National Health Service and within the occupational therapy profession. Particular attention is given to the role of the employee as a consumer within the NHS and also to the role of the client as a consumer without. Their respective parts in the assurance of quality are explored. In addition, the need for standards to be set and monitored in current occupational therapy practice is emphasised, with responsibility centred on the profession itself. The increasing need to involve the satisfaction of the client consumer as a measure of outcome is also suggested as part of the assurance of quality.

The Role of Health Professionals

2020 ◽  
pp. 66-88
Keyword(s):  
European Union ◽  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Health Professionals ◽  
Power Relations ◽  
Decision To Leave ◽  
Professional Practitioners ◽  
The Eu

Staff governance is a major challenge for the NHS. It refers to the framework for managing employees in the National Health Service (NHS). Professional practitioners, in particular doctors and nurses, have a key role to play in the running of the NHS, but there are many challenges in managing staff and especially ensuring high retention levels. This chapter begins by explaining the power relations within the NHS and among some of the key actors. It then highlights some of the key challenges including those posed by the loss of European Union (EU) staff following the UK's decision to leave the EU. In particular, it explains why it has become increasingly difficult in recent years to retain staff in the NHS. It then discusses some of the measures to stem the haemorrhaging of staff.

scholarly journals A closer look at how managerial support can help improve patient experience: Insights from the UK’s National Health Service

2020 ◽  
pp. 001872672093883
Author(s):  
Chidiebere Ogbonnaya ◽  
Mayowa T Babalola
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Patient Experience ◽  
National Health ◽  
Organizational Support ◽  
Quality Of Healthcare ◽  
Perceived Supervisor Support ◽  
Managerial Support

Recent debates in healthcare have emphasized the need for more respectful and responsive services that meet patients’ preferences. These debates centre on patient experience, one of the most critical factors for measuring healthcare performance. In exploring the relevance of patient experience key questions need answers: what can managers or supervisors do to help improve the quality of healthcare? What is the role of employees? Addressing these questions, this study examines whether perceived supervisor support (PSS) promotes patient experience through a serial mediation involving perceived organizational support (POS), and positive employee outcomes such as engagement, involvement and advocacy. Using two-wave data from the British National Health Service, we show that PSS is strongly associated with POS, which in turn improves engagement, involvement and advocacy among employees. PSS also has a positive indirect influence on patient experience through POS and advocacy; but the indirect paths involving engagement and involvement are not supported. We offer useful guidance on how healthcare employers can support employees towards improving the quality of services rendered to patients.

The lost worlds of royal commissions in the NHS: The unaccountable in pursuit of the unanswerable?

2019 ◽  
Vol 37 (2) ◽  
pp. 199-217
Author(s):  
Martin Powell
Keyword(s):  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Royal Commission ◽  
Select Committee ◽  
House Of Lords ◽  
The Impact ◽  
British National Health ◽  
Advisory Bodies

There have been recent calls for a royal commission (RC) on the British National Health Service (NHS). This article focuses on the impact of RCs and similar advisory bodies, particularly on finance recommendations, of three inquiries with broad remits across the whole of the NHS from very different periods: Guillebaud (1956); Royal Commission on the National Health Service (1979); and House of Lords Select Committee on the Long-term Sustainability of the NHS (2017). These inquiries appear to have had rather limited impacts, especially on NHS funding. First, there appears to be some hesitancy in suggesting precise figures for NHS expenditure. Second, the reports are advisory, and governments can ignore their conclusions. Third, governments have ignored their conclusions. In the 1950s and the 1980s, contrary to the recommendations of the inquiries, NHS expenditure subsequently grew only slowly, and charges were increased. In short, asking an independent RC to provide answers on NHS expenditure is perhaps the unaccountable in pursuit of the unanswerable.

More Patient Choice in England's National Health Service

2005 ◽  
Vol 35 (3) ◽  
pp. 479-483 ◽  
Author(s):  
Richard Lewis
Keyword(s):  
Health Care ◽  
National Health Service ◽  
Health Service ◽  
National Health ◽  
Urban Areas ◽  
Patient Choice ◽  
Private Provider ◽  
National Quality ◽  
The Government ◽  
English National Health

A new political consensus has emerged over the benefits of new rights for patients to choose their provider of elective health care in the English National Health Service. From December 2005, patients will be able to select from a number of alternative providers at the time they are referred for treatment. In the longer term, patients will be able to access care at any public or private provider that meets national quality and cost standards. The government intends that this policy will lead to improvements in the quality and efficiency of health care and will reduce levels of inequity among patients. Pilot schemes have shown that a majority of patients will exercise a choice of provider when this is offered. However, the policy of patient choice may involve significant costs to the NHS and may be more difficult to implement outside urban areas. Further, the information needed to support patients' choices is not yet available. Whether such a policy will increase or decrease levels of equity in the English NHS remains open to debate.

Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England

2009 ◽  
Vol 25 (03) ◽  
pp. 262-271 ◽  
Author(s):  
Eva Susanne Dietrich
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Ambulatory Care ◽  
National Health ◽  
Role Model ◽  
Regression Analyses ◽  
England And Wales ◽  
Department Of Health ◽  
Prescription Costs ◽  
The Impact

Objectives:The aim of this study was to examine the impact of the National Institute for Health and Clinical Excellence's (NICE's) negative and restricting technology appraisals on the number of prescription items dispensed and the corresponding total net ingredient costs for drugs from 2000 to 2004 in the ambulatory care of the National Health Service (NHS) in England and Wales. In addition, it is discussed whether the NICE approach could be a role model for Germany.Methods:The number of prescription items dispensed and the net ingredient costs of thirty-one drugs reimbursed by the NHS were analyzed, thereof thirteen drugs descriptively and twenty-one drugs with regression analyses. Data were extracted from the “Prescription-Costs-Analysis-Statistics” for the ambulatory care of the British Department of Health (England 1993–2005). In the case of the twenty-one drugs analyzed by regression analyses, predictions were established how the prescribing and the costs would have developed without NICE's drug appraisal. Finally, conclusions were drawn whether NICE's negative and restricting drug appraisals had a decreasing effect or not.Results:For 97 percent of the drugs analyzed in this study, the publication of NICE's fourteen negative and restricting technology appraisals of drugs between 2000 and 2004 did not reduce the number of prescription items dispensed and net ingredient costs in the ambulatory care of the NHS in England and Wales.Conclusions:Cost-effectiveness appraisals as performed by NICE or the German Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) are a useful and important tool to enhance the discussion about methods and acceptance of evidence-based medicine in general.

Sign in / Sign up

Export Citation Format

Share Document